Importantly, Pieri and collaborators first demonstrated that basophils from JAK2 V617F PV patients overexpressed CD63, a marker of basophil activation (39), compared to controls when challenged with IL-3 plus fMLP (21). Here, JAK2 is linked to acquired polycythemia vera.